The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Belosevic, M.
Right arrow Articles by Nacy, C. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Belosevic, M.
Right arrow Articles by Nacy, C. A.

The Journal of Immunology, Vol 143, Issue 1 266-274, Copyright © 1989 by American Association of Immunologists

ARTICLES

Administration of monoclonal anti-IFN-gamma antibodies in vivo abrogates natural resistance of C3H/HeN mice to infection with Leishmania major

M Belosevic, DS Finbloom, PH Van Der Meide, MV Slayter and CA Nacy
Department of Cellular Immunology, Walter Reed Army Institute of Research, Washington, DC 20307-5100.

C3H/HeN mice that are naturally resistant to cutaneous disease and systemic infections with the protozoan parasite, Leishmania major, were treated at the time of infection, and weekly thereafter, with mouse anti-rat IFN-gamma mAb or an irrelevant antibody of similar isotype. Anti-IFN-gamma-treated mice developed cutaneous lesions; parasites spread to the regional lymph nodes and then metastasized to spleens and livers. The course of disease in these animals was similar to that of genetically susceptible BALB/c mice. Two exceptions in the pathology of L. major infections were noted between BALB/c and anti-IFN-gamma- treated C3H/HeN mice: 1) BALB/c mice died of systemic complications, whereas C3H/HeN mice did not, and 2) multinucleated giant cells were observed in lymph nodes and spleens of infected BALB/c mice, whereas these cells were not observed in infected C3H/HeN mice. Control mice, those treated with either saline or irrelevant antibody of the same isotype as the anti-IFN-gamma monoclonal, showed no evidence of cutaneous disease (development of footpad lesions) or systemic infection (by histopathology). Total abrogation of the natural resistance of C3H/HeN mice could be achieved by treatment with as little as 0.5 mg/mouse/wk of anti-IFN-gamma antibody, or by a single dose of 1 mg/mouse anti-IFN-gamma antibody administered at the time of parasite inoculation. If antibody treatment was delayed for as little as 1 wk after parasite inoculation, the infections in treated animals resembled that of untreated or control antibody-treated mice: no cutaneous lesions (by footpad swelling or viable counts of leishmania in footpad tissue) or systemic disease (by microscopic analysis of touch preparations of internal organs, and histopathology of same). The production of IFN-gamma during the initial interaction of the parasite and host cells appears to be a major component of genetic control of natural resistance to infection with L. major in C3H/HeN mice.


This article has been cited by other articles:


Home page
 Infect. Immun.Home page
S. Reckling, S. Divanovic, C. L. Karp, S. Wojciechowski, Y. Belkaid, and D. Hildeman
Proapoptotic Bcl-2 Family Member Bim Promotes Persistent Infection and Limits Protective Immunity
Infect. Immun., March 1, 2008; 76(3): 1179 - 1185.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
F. J. S. Rocha, U. Schleicher, J. Mattner, G. Alber, and C. Bogdan
Cytokines, Signaling Pathways, and Effector Molecules Required for the Control of Leishmania (Viannia) braziliensis in Mice
Infect. Immun., August 1, 2007; 75(8): 3823 - 3832.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
K. Nagatani, M. Dohi, Y. To, R. Tanaka, K. Okunishi, K. Nakagome, K. Sagawa, Y. Tanno, Y. Komagata, and K. Yamamoto
Splenic Dendritic Cells Induced by Oral Antigen Administration Are Important for the Transfer of Oral Tolerance in an Experimental Model of Asthma
J. Immunol., February 1, 2006; 176(3): 1481 - 1489.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
A. Rivera, H. L. Van Epps, T. M. Hohl, G. Rizzuto, and E. G. Pamer
Distinct CD4+-T-Cell Responses to Live and Heat-Inactivated Aspergillus fumigatus Conidia
Infect. Immun., November 1, 2005; 73(11): 7170 - 7179.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
C. F. Anderson, S. Mendez, and D. L. Sacks
Nonhealing Infection despite Th1 Polarization Produced by a Strain of Leishmania major in C57BL/6 Mice
J. Immunol., March 1, 2005; 174(5): 2934 - 2941.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
C. M. Theodos, R. V. Morris, J. V. Bishop, J. D. Jones, W. R. McMaster, and R. G. Titus
Characterization of an I-E-Restricted, gp63-Specific, CD4-T-Cell Clone from Leishmania major-Resistant C3H Mice That Secretes Type 2 Cytokines and Exacerbates Infection with L. major
Infect. Immun., August 1, 2004; 72(8): 4486 - 4493.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
P. Bocek Jr., G. Foucras, and W. E. Paul
Interferon {gamma} Enhances Both In Vitro and In Vivo Priming of CD4+ T Cells for IL-4 Production
J. Exp. Med., June 21, 2004; 199(12): 1619 - 1630.
[Abstract] [Full Text] [PDF]

Home page
 J. Gen. Virol.Home page
C. Ramakrishna, V. Ravi, A. Desai, D. K. Subbakrishna, S. K. Shankar, and A. Chandramuki
T helper responses to Japanese encephalitis virus infection are dependent on the route of inoculation and the strain of mouse used
J. Gen. Virol., June 1, 2003; 84(6): 1559 - 1567.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
T. Lang, N. Courret, J.-H. Colle, G. Milon, and J.-C. Antoine
The Levels and Patterns of Cytokines Produced by CD4 T Lymphocytes of BALB/c Mice Infected with Leishmania major by Inoculation into the Ear Dermis Depend on the Infectiousness and Size of the Inoculum
Infect. Immun., May 1, 2003; 71(5): 2674 - 2683.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. D. Hess, N. K. Egilmez, N. Bailey, T. M. Anderson, E. Mathiowitz, S. H. Bernstein, and R. B. Bankert
Human CD4+ T Cells Present Within the Microenvironment of Human Lung Tumors Are Mobilized by the Local and Sustained Release of IL-12 to Kill Tumors In Situ by Indirect Effects of IFN-{gamma}
J. Immunol., January 1, 2003; 170(1): 400 - 412.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
Y. Belkaid, E. Von Stebut, S. Mendez, R. Lira, E. Caler, S. Bertholet, M. C. Udey, and D. Sacks
CD8+ T Cells Are Required for Primary Immunity in C57BL/6 Mice Following Low-Dose, Intradermal Challenge with Leishmania major
J. Immunol., April 15, 2002; 168(8): 3992 - 4000.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
Y. Kim, S.-s. J. Sung, W. A. Kuziel, S. Feldman, S. M. Fu, and C. E. Rose Jr
Enhanced Airway Th2 Response After Allergen Challenge in Mice Deficient in CC Chemokine Receptor-2 (CCR2)
J. Immunol., April 15, 2001; 166(8): 5183 - 5192.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
D. J. Herzyk, E. R. Gore, R. Polsky, K. L. Nadwodny, C. C. Maier, S. Liu, T. K. Hart, A. G. Harmsen, and P. J. Bugelski
Immunomodulatory Effects of Anti-CD4 Antibody in Host Resistance against Infections and Tumors in Human CD4 Transgenic Mice
Infect. Immun., February 1, 2001; 69(2): 1032 - 1043.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
R. Lira, M. Doherty, G. Modi, and D. Sacks
Evolution of Lesion Formation, Parasitic Load, Immune Response, and Reservoir Potential in C57BL/6 Mice following High- and Low-Dose Challenge with Leishmania major
Infect. Immun., September 1, 2000; 68(9): 5176 - 5182.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
Y. Belkaid, S. Mendez, R. Lira, N. Kadambi, G. Milon, and D. Sacks
A Natural Model of Leishmania major Infection Reveals a Prolonged ""Silent"" Phase of Parasite Amplification in the Skin Before the Onset of Lesion Formation and Immunity
J. Immunol., July 15, 2000; 165(2): 969 - 977.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
K. Ohkusu, T. Yoshimoto, K. Takeda, T. Ogura, S.-i. Kashiwamura, Y. Iwakura, S. Akira, H. Okamura, and K. Nakanishi
Potentiality of Interleukin-18 as a Useful Reagent for Treatment and Prevention of Leishmania major Infection
Infect. Immun., May 1, 2000; 68(5): 2449 - 2456.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
H. R. Chakkalath, A. A. Siddiqui, A. H. Shankar, D. E. Dobson, S. M. Beverley, and R. G. Titus
Priming of a beta -Galactosidase (beta -GAL)-Specific Type 1 Response in BALB/c Mice Infected with beta -GAL-Transfected Leishmania major
Infect. Immun., February 1, 2000; 68(2): 809 - 814.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
D. J. Matthews, C. L. Emson, G. J. McKenzie, H. E. Jolin, J. M. Blackwell, and A. N. J. McKenzie
IL-13 Is a Susceptibility Factor for Leishmania major Infection
J. Immunol., February 1, 2000; 164(3): 1458 - 1462.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
T. Fukao, S. Matsuda, and S. Koyasu
Synergistic Effects of IL-4 and IL-18 on IL-12-Dependent IFN-{gamma} Production by Dendritic Cells
J. Immunol., January 1, 2000; 164(1): 64 - 71.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
K. KUMANO, A. NAKAO, H. NAKAJIMA, F. HAYASHI, M. KURIMOTO, H. OKAMURA, Y. SAITO, and I. IWAMOTO
Interleukin-18 Enhances Antigen-induced Eosinophil Recruitment into the Mouse Airways
Am. J. Respir. Crit. Care Med., September 1, 1999; 160(3): 873 - 878.
[Abstract] [Full Text]

Home page
 J. Immunol.Home page
N. Noben-Trauth, W. E. Paul, and D. L. Sacks
IL-4- and IL-4 Receptor-Deficient BALB/c Mice Reveal Differences in Susceptibility to Leishmania major Parasite Substrains
J. Immunol., May 15, 1999; 162(10): 6132 - 6140.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. L. Guler, J. D. Gorham, W. F. Dietrich, T. L. Murphy, R. G. Steen, C. A. Parvin, D. Fenoglio, A. Grupe, G. Peltz, and K. M. Murphy
Tpm1, a Locus Controlling IL-12 Responsiveness, Acts by a Cell-Autonomous Mechanism
J. Immunol., February 1, 1999; 162(3): 1339 - 1347.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. Bushell, M. Niimi, P. J. Morris, and K. J. Wood
Evidence for Immune Regulation in the Induction of Transplantation Tolerance: A Conditional but Limited Role for IL-4
J. Immunol., February 1, 1999; 162(3): 1359 - 1366.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
C. R. Gabaglia, B. Pedersen, M. Hitt, N. Burdin, E. E. Sercarz, F. L. Graham, J. Gauldie, and T. A. Braciak
A Single Intramuscular Injection with an Adenovirus- Expressing IL-12 Protects BALB/c Mice Against Leishmania major Infection, While Treatment with an IL-4-Expressing Vector Increases Disease Susceptibility in B10.D2 Mice
J. Immunol., January 15, 1999; 162(2): 753 - 760.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. Li, C. A. Hunter, and J. P. Farrell
Anti-TGF-{beta} Treatment Promotes Rapid Healing of Leishmania major Infection in Mice by Enhancing In Vivo Nitric Oxide Production
J. Immunol., January 15, 1999; 162(2): 974 - 979.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
A. Gasser and J. Most
Generation of Multinucleated Giant Cells In Vitro by Culture of Human Monocytes with Mycobacterium bovis BCG in Combination with Cytokine-Containing Supernatants
Infect. Immun., January 1, 1999; 67(1): 395 - 402.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
K. Hung, R. Hayashi, A. Lafond-Walker, C. Lowenstein, D. Pardoll, and H. Levitsky
The Central Role of CD4+ T Cells in the Antitumor Immune Response
J. Exp. Med., December 21, 1998; 188(12): 2357 - 2368.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. Alexander, G. H. Coombs, and J. C. Mottram
Leishmania mexicana Cysteine Proteinase-Deficient Mutants Have Attenuated Virulence for Mice and Potentiate a Th1 Response
J. Immunol., December 15, 1998; 161(12): 6794 - 6801.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
L. M. Stamm, A. Raisanen-Sokolowski, M. Okano, M. E. Russell, J. R. David, and A. R. Satoskar
Mice with STAT6-Targeted Gene Disruption Develop a Th1 Response and Control Cutaneous Leishmaniasis
J. Immunol., December 1, 1998; 161(11): 6180 - 6188.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. L. Mbow, J. A. Bleyenberg, L. R. Hall, and R. G. Titus
Phlebotomus papatasi Sand Fly Salivary Gland Lysate Down-Regulates a Th1, but Up-Regulates a Th2, Response in Mice Infected with Leishmania major
J. Immunol., November 15, 1998; 161(10): 5571 - 5577.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
Y. Maekawa, K. Himeno, H. Ishikawa, H. Hisaeda, T. Sakai, T. Dainichi, T. Asao, R. A Good, and N. Katunuma
Switch of CD4+ T Cell Differentiation from Th2 to Th1 by Treatment with Cathepsin B Inhibitor in Experimental Leishmaniasis
J. Immunol., September 1, 1998; 161(5): 2120 - 2127.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
N. Hirji, T.-J. Lin, E. Bissonnette, M. Belosevic, and A. D. Befus
Mechanisms of Macrophage Stimulation Through CD8: Macrophage CD8{alpha} and CD8{beta} Induce Nitric Oxide Production and Associated Killing of the Parasite Leishmania major
J. Immunol., June 15, 1998; 160(12): 6004 - 6011.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
G. R. Beretich Jr., P. B. Carter, and E. A. Havell
Roles for Tumor Necrosis Factor and Gamma Interferon in Resistance to Enteric Listeriosis
Infect. Immun., May 1, 1998; 66(5): 2368 - 2373.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
Q. Ning, D. Brown, J. Parodo, M. Cattral, R. Gorczynski, E. Cole, L. Fung, J. W. Ding, M. F. Liu, O. Rotstein, et al.
Ribavirin Inhibits Viral-Induced Macrophage Production of TNF, IL-1, the Procoagulant fgl2 Prothrombinase and Preserves Th1 Cytokine Production But Inhibits Th2 Cytokine Response
J. Immunol., April 1, 1998; 160(7): 3487 - 3493.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
K. Shibuya, D. Robinson, F. Zonin, S. B. Hartley, S. E. Macatonia, C. Somoza, C. A. Hunter, K. M. Murphy, and A. O'Garra
IL-1{alpha} and TNF-{alpha} Are Required for IL-12-Induced Development of Th1 Cells Producing High Levels of IFN-{gamma} in BALB/c But Not C57BL/6 Mice
J. Immunol., February 15, 1998; 160(4): 1708 - 1716.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
G. K. DeKrey, H. C. Lima, and R. G. Titus
Analysis of the Immune Responses of Mice to Infection with Leishmania braziliensis
Infect. Immun., February 1, 1998; 66(2): 827 - 829.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. L. Reiner, D. J. Fowell, N. H. Moskowitz, K. Swier, D. R. Brown, C. R. Brown, C. W. Turck, P. A. Scott2, N. Killeen, and R. M. Locksley3
Control of Leishmania major by a Monoclonal {alpha}{beta} T Cell Repertoire
J. Immunol., January 15, 1998; 160(2): 884 - 889.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
J. Most, L. Spotl, G. Mayr, A. Gasser, A. Sarti, and M. P. Dierich
Formation of Multinucleated Giant Cells In Vitro Is Dependent on the Stage of Monocyte to Macrophage Maturation
Blood, January 15, 1997; 89(2): 662 - 671.
[Abstract] [Full Text] [PDF]

Home page
 ScienceHome page
E Mougneau, F Altare, A. Wakil, S Zheng, T Coppola, Z. Wang, R Waldmann, R. Locksley, and N Glaichenhaus
Expression cloning of a protective Leishmania antigen
Science, April 28, 1995; 268(5210): 563 - 566.
[Abstract] [PDF]

Home page
 ScienceHome page
R. Locksley, S. Reiner, F Hatam, D. Littman, and N Killeen
Helper T cells without CD4: control of leishmaniasis in CD4-deficient mice
Science, September 10, 1993; 261(5127): 1448 - 1451.
[Abstract] [PDF]

Home page
 ScienceHome page
S. Reiner, Z. Wang, F Hatam, P Scott, and R. Locksley
TH1 and TH2 cell antigen receptors in experimental leishmaniasis
Science, March 5, 1993; 259(5100): 1457 - 1460.
[Abstract] [PDF]

Home page
 ScienceHome page
M Barral-Netto, A Barral, C. Brownell, Y. Skeiky, L. Ellingsworth, D. Twardzik, and S. Reed
Transforming growth factor-beta in leishmanial infection: a parasite escape mechanism
Science, July 24, 1992; 257(5069): 545 - 548.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1989 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1989 by The American Association of Immunologists, Inc. All rights reserved.